Medicines for diagnostic imaging agents under CP 2024/960 of SPMS, for the YEAR 2026

This tender concerns the procurement of medicines specifically used as diagnostic imaging agents. The acquisition is being made under framework contract CP 2024/960, managed by SPMS (Serviços Partilhados do Ministério da Saúde - Shared Services of the Ministry of Health). The supply is intended for the year 2026. The scope of this procurement includes various pharmaceutical products essential for medical imaging procedures such as X-rays, CT scans, MRI scans, and ultrasound. These agents are crucial for enhancing the visibility of internal body structures, aiding in accurate diagnosis and treatment planning. The tender specifies the types of diagnostic imaging agents required, their quality standards, packaging, and delivery schedules. SPMS, as the central purchasing body, aims to secure competitive pricing and ensure a reliable supply chain for these critical medical consumables across the national health system. Bidders are expected to be pharmaceutical manufacturers or authorized distributors with the capacity to meet the demands for these specialized medicines. Compliance with all relevant pharmaceutical regulations and quality assurance protocols is mandatory. The objective is to guarantee the availability of necessary imaging agents for healthcare providers throughout 2026.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 13,735.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.